← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Kathera Bioscience Inc.
Union, NJ
$2,189,220
Total funding
3
Grants
Funding over time
peak $995.1K · FY2021–25$1M$750K$500K$250K$0
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,189,220 · 3
By mechanism
R44$1,293,630 · 1
R43$895,590 · 2
Investigators at Kathera Bioscience Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
All-Time
Most funded here, all years
Largest grants
Novel Broad Spectrum Inhibitors of Dihydrofolate Reductase (DHFR) for Treatment of Infections from High Threat Fungal Pathogens$995,100
R44 · FY2025 · AI
A Redesigning Existing Drugs against Indispensable Targets (ReEDIT) platform technology for discovery of novel drugs to treat fungal infections$298,530
R43 · FY2023 · AI
Novel Broad Spectrum Inhibitors of Dihydrofolate Reductase (DHFR) for Treatment of Infections from High Threat Fungal Pathogens$298,530
R44 · FY2024 · AI
A Redesigning Existing Drugs against Indispensable Targets (ReEDIT) platform technology for discovery of novel drugs to treat fungal infections$298,530
R43 · FY2024 · AI
Ess1: A pathogenic fungal target for a novel class of broad-spectrum therapeutic agents$298,530
R43 · FY2021 · AI